Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seitz-Polski

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2023
Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated SyndromesMichael Levraut, Antoine Gavoille, Cassandre Landes-Chateau, et al.
Clinical Kidney Journal|April 12, 2017
Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathyPerrine Jullien, Barbara Seitz Polski, Nicolas Maillard, et al.
Stem Cell Reviews and Reports|October 26, 2022
Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic PapersJérôme Barrière, Fabrice Frank, Lonni Besançon, et al.
Frontiers in Immunology|November 1, 2021
Rituximab Immunomonitoring Predicts Remission in Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Frontiers in Immunology|May 23, 2022
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2022
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position articleJérôme Barrière, Michel Carles, Clarisse Audigier-Valette, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 25, 2022
Toxic Occupational Exposures and Membranous NephropathyMarion Cremoni, Sophie Agbekodo, Maxime Teisseyre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2019
Rituximab bioavailability in primary membranous nephropathySonia Boyer-Suavet, Marine Andreani, Marion Cremoni, et al.
Journal of Neurology|June 9, 2025
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatmentCharlotte Héraud, Saskia Bresch, Véronique Bourg, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2017
Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous NephropathyBarbara Seitz-Polski, Hanna Debiec, Alexandra Rousseau, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2023
Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated SyndromesMichael Levraut, Antoine Gavoille, Cassandre Landes-Chateau, et al.
Clinical Kidney Journal|April 12, 2017
Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathyPerrine Jullien, Barbara Seitz Polski, Nicolas Maillard, et al.
Stem Cell Reviews and Reports|October 26, 2022
Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic PapersJérôme Barrière, Fabrice Frank, Lonni Besançon, et al.
Frontiers in Immunology|November 1, 2021
Rituximab Immunomonitoring Predicts Remission in Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
Frontiers in Immunology|May 23, 2022
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous NephropathyMaxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2022
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position articleJérôme Barrière, Michel Carles, Clarisse Audigier-Valette, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 25, 2022
Toxic Occupational Exposures and Membranous NephropathyMarion Cremoni, Sophie Agbekodo, Maxime Teisseyre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2019
Rituximab bioavailability in primary membranous nephropathySonia Boyer-Suavet, Marine Andreani, Marion Cremoni, et al.
Journal of Neurology|June 9, 2025
Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatmentCharlotte Héraud, Saskia Bresch, Véronique Bourg, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2017
Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous NephropathyBarbara Seitz-Polski, Hanna Debiec, Alexandra Rousseau, et al.
Pageof 8